[Contralateral comparison between diflucortolone valeriante and flumethasone pivalate in ointments. Double-blind...

Area of Science:

• Dermatology
• Pharmacology

Background:

• Topical corticosteroids are mainstays in treating inflammatory dermatoses.
• Comparing potencies and efficacies of different corticosteroids is crucial for optimal treatment selection.

Purpose of the Study:

• To compare the efficacy and safety of diflucortolone valerate 0.1% versus flumetasone pivalate 0.02% in pomade formulations.
• To evaluate treatment outcomes in patients with psoriasis, eczema vario, and neurodermatitis.

Main Methods:

• A double-blind, contralateral comparison study.
• Inclusion of 52 patients (both sexes, variable ages) with bilateral, symmetrical inflammatory dermatological lesions.
• Assessment of efficacy and safety of topical diflucortolone valerate and flumetasone pivalate.

Main Results:

• Diflucortolone valerate demonstrated superior efficacy in treating psoriasis.
• Similar efficacy was observed between the two corticosteroids in eczema vario and neurodermatitis.
• No significant adverse secondary effects were reported for either treatment at the specified doses and duration.

Conclusions:

• Both diflucortolone valerate 0.1% and flumetasone pivalate 0.02% are effective topical treatments for inflammatory skin conditions.
• Diflucortolone valerate may offer an advantage in managing psoriasis.
• The studied formulations exhibit a favorable safety profile.